{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:39:34Z","timestamp":1792427974922,"version":"4.5.0"},"reference-count":44,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Clin Pharmacol"],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Cefepime is commonly used in critically ill children for whom there is a high between\u2010subject variability. To reach the therapeutic pharmacokinetic (PK) target in critically ill patients, prolonged infusion of beta\u2010lactams seems to be the most efficient. The aim of this study was to compare cefepime exposure between prolonged and intermittent infusions in critically ill children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This prospective observational study was conducted in two paediatric intensive care units. Children with a cefepime plasma concentration measurement were included. Steady\u2010state free residual and plateau concentrations were estimated using Bayesian forecasting. The PK target was defined as 100%\n                      <jats:italic>f<\/jats:italic>\n                      T\n                      <jats:sub>\u22654xMIC<\/jats:sub>\n                      . Exposure was compared using the minimum inhibitory concentrations (MICs) of the pathogens identified in the patients. The probability of target attainment (PTA) was also compared using various MICs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventy\u2010eight antibiotic courses in 75 patients were included, divided into 19 prolonged infusions and 59 intermittent infusions. Prolonged and intermittent infusions were comparable for optimal exposure (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910\/19, 53%\n                      <jats:italic>vs. n<\/jats:italic>\n                      \u2009=\u200935\/59, 59%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.79). Overexposure tended to be more frequent with prolonged infusion (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098\/19, 42%\n                      <jats:italic>vs. n<\/jats:italic>\n                      \u2009=\u200916\/59, 27%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.26), whereas underexposure tended to be less common with prolonged infusion (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091\/19, 5%\n                      <jats:italic>vs. n<\/jats:italic>\n                      \u2009=\u20098\/59, 14%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.44). Considering the wide range of MICs, the PTA was comparable for MIC\u2009&lt;\u20091\u2009mg\/L but was significantly higher for prolonged infusion for MIC\u2009\u2265\u20091\u2009mg\/L (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Prolonged infusion of cefepime provides a higher PTA when MIC is \u22651\u2009mg\/L compared with intermittent infusion. This result suggests the superiority of prolonged infusion for high MIC bacteria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/bcp.70804","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:10:37Z","timestamp":1789027837000},"source":"Crossref","is-referenced-by-count":1,"title":["Cefepime exposure in prolonged or intermittent infusion in critically ill children"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2907-6387","authenticated-orcid":false,"given":"Marc","family":"Hobeika","sequence":"first","affiliation":[{"name":"Department of Pediatric Intensive Care Necker\u2010Enfants Malades Hospital, AP\u2010HP.Centre, Universit\u00e9 Paris Cit\u00e9  Paris Ile\u2010de\u2010France France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Hirt","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology Cochin Hospital  Paris Ile\u2010de\u2010France France"},{"name":"INSERM UMR1343 Pharmacology and Therapeutics Evaluation for Children and Pregnant Women  Paris Ile\u2010de\u2010France France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Bille","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology Necker\u2010Enfants Malades Hospital, APHP  Paris Ile\u2010de\u2010France France"},{"name":"INSERM U1151 CNRS UMR8253  Paris Ile\u2010de\u2010France France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihem","family":"Benaboud","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology Cochin Hospital  Paris Ile\u2010de\u2010France France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Toubiana","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics and Pediatric Infectious Diseases Necker\u2010Enfants Malades Hospital  Paris Ile\u2010de\u2010France France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre\u2010Louis","family":"L\u00e9ger","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Armand Trousseau Hospital, APHP, Sorbonne Universit\u00e9  Paris Ile\u2010de\u2010France France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Rambaud","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Armand Trousseau Hospital, APHP, Sorbonne Universit\u00e9  Paris Ile\u2010de\u2010France France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"B\u00e9ranger","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Necker\u2010Enfants Malades Hospital, AP\u2010HP.Centre, Universit\u00e9 Paris Cit\u00e9  Paris Ile\u2010de\u2010France France"},{"name":"INSERM UMR1343 Pharmacology and Therapeutics Evaluation for Children and Pregnant Women  Paris Ile\u2010de\u2010France France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Callot","sequence":"additional","affiliation":[{"name":"Regional Pharmacovigilance Center Cochin Hospital  Paris Ile\u2010de\u2010France France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Renolleau","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Necker\u2010Enfants Malades Hospital, AP\u2010HP.Centre, Universit\u00e9 Paris Cit\u00e9  Paris Ile\u2010de\u2010France France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2045-4742","authenticated-orcid":false,"given":"Jean\u2010Marc","family":"Treluyer","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology Cochin Hospital  Paris Ile\u2010de\u2010France France"},{"name":"INSERM UMR1343 Pharmacology and Therapeutics Evaluation for Children and Pregnant Women  Paris Ile\u2010de\u2010France France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0488-5948","authenticated-orcid":false,"given":"Mehdi","family":"Oualha","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Necker\u2010Enfants Malades Hospital, AP\u2010HP.Centre, Universit\u00e9 Paris Cit\u00e9  Paris Ile\u2010de\u2010France France"},{"name":"INSERM UMR1343 Pharmacology and Therapeutics Evaluation for Children and Pregnant Women  Paris Ile\u2010de\u2010France France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4280-4683","authenticated-orcid":false,"given":"No\u00e9mie","family":"de Cacqueray","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Necker\u2010Enfants Malades Hospital, AP\u2010HP.Centre, Universit\u00e9 Paris Cit\u00e9  Paris Ile\u2010de\u2010France France"},{"name":"INSERM UMR1343 Pharmacology and Therapeutics Evaluation for Children and Pregnant Women  Paris Ile\u2010de\u2010France France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02224"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002817"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1284"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095\u2010016\u20102033\u2010y"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000002198"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054\u2010019\u20102378\u20109"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265\u2010023\u201001893\u20106"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.9779"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431\u2010022\u201004716\u20100"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.16224"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2024.101354"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.05.007"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.PCC.0000149131.72248.E6"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(03)13908\u20106"},{"issue":"2","key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine","volume":"58","author":"Schwartz GJ","year":"1976","journal-title":"Pediatrics"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467\u2010019\u201004205\u2010x"},{"key":"e_1_2_10_18_1","unstructured":"European Committee on Antimicrobial Susceptibility Testing.EUCAST general website.http:\/\/www.eucast.org"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.27.2.207"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01595\u201008"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2015.10.009"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.01.005"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.70229"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9071505"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054\u2010017\u20101856\u20101"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks012"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L307"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.1217"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2012.08.017"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13842"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/08971900221125000"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa373"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.5863\/1551\u20106776\u201026.8.828"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2022.154011"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40560\u2010018\u20100330\u20108"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.05.020"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02006\u201018"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.5863\/1551\u20106776\u201028.2.167"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/2110\u20105820\u20102\u201037"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134\u2010015\u20104188\u20100"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201601\u20100024OC"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/121934"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879\u2010020\u201005149\u20106"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.9803"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1R216"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70804","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bcp.70804","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70804","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:10:39Z","timestamp":1789027839000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/bcp.70804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":44,"alternative-id":["10.1002\/bcp.70804"],"URL":"https:\/\/doi.org\/10.1002\/bcp.70804","archive":["Portico"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.22541\/au.175381766.64058132\/v1","asserted-by":"object"}]},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"bcp.70804"}}